BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2006
View Archived Issues
CKD-501 well tolerated in healthy subjects
Read More
Dopamine receptor occupancy of YKP-1358 determined
Read More
Potential antitumor activity of SIRT1 inhibitors / News in Context
Read More
Neurocrine Biosciences updates progress across pipeline
Read More
Neuromed supports calcium channel blocker programs with Series D financing
Read More
AC Immune identifies lead compounds for Alzheimer's disease
Read More
Epix completes enrollment in phase IIb study of EP-2104R
Read More
Allergan receives FTC approval for Inamed acquisition
Read More
VX-702 produces dose-dependent increase in ACR20 response rates
Read More
ALGRX-4975 meets primary endpoint of decreased pain for tendonitis patients
Read More
Active RA patients achieve ACR20 following HuMax-CD20 treatment
Read More
Snapshots of new dental research
Read More
Dimethylcurcumin claimed as a potential topical agent for acne vulgaris
Read More
Ad-IU-1 shows good profile as gene therapy for prostate cancer
Read More
Acadia presents new nonpeptidergic UII receptor agonists
Read More
XMRV: A novel virus behind prostate cancer?
Read More
Anticancer efficacy of satraplatin in vitro, in vivo and in patients with advanced solid tumors
Read More
Nikken Chemical obtains manufacturing and marketing rights for Selenica tablet
Read More
CV Therapeutics begins shipments of Ranexa
Read More
IND clearance for pharmacokinetic study of Nebido
Read More
New phase II study for SP-01A in treatment experienced HIV-infected patients
Read More
NICE recommends PDT to treat common skin cancer and premalignant lesions
Read More
LA-419 effective in a human model of thrombosis
Read More
GPR119 agonist identified and found to reduce food intake in a rat model of obesity
Read More
Kowa acquires the remaining common shares of Nikken Chemicals, bringing its ownership to 100%
Read More
StemCells receives IRB approval for phase I Batten disease study of HuCNS-SC
Read More
Kamada cleared to begin phase III trials of alpha1-proteinase inhibitor
Read More
Braintree inlicenses rights to chemoprevention agent BLI-600
Read More
Amgen updates AMG-714 progress
Read More
New antiglaucoma agents disclosed in recent patents
Read More
Anti-HCV drugs prepared and tested at Bristol-Myers Squibb
Read More
New patents describe therapeutic agents for asthma, COPD, emphysema, etc.
Read More
